Testing starch and a drug after stem cell transplant
Part of Blood & lymphatic, Digestive system, Immune system & allergy clinical trials.
This trial tests if adding a special starch and a drug called deferasirox can improve recovery for people who have a stem cell transplant for blood disorders. The starch may help with gut health and the drug reduces iron, which might help prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are getting a stem cell transplant from a fully matched donor (related or unrelated) after strong chemo or radiation
- You are 18 years or older
- You are in good physical function (able to do most daily activities)
- You are able to swallow pills
- You do not have active inflammatory bowel disease or have had gastric bypass surgery
- You do not have active C. diff infection or iron deficiency anemia needing treatment
- You are not already taking deferasirox for iron overload
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a high-fiber diet program can help people who are about to have a stem cell transplant from a donor. It aims to see if increasing fiber intake during this time is safe and helpful.
This trial tests whether a special probiotic made from the patient's own gut bacteria and their donor's can help fix gut problems caused by a complication called graft-versus-host disease (aGVHD) after a stem cell transplant. It might help patients who are over 50 and scheduled for a specific type of transplant.
This Phase 2 study tests an oral “fecal microbiotherapy” treatment given before and around an allogeneic (donor) stem-cell transplant to help prevent transplant-related complications. It may help by improving gut and immune function during the high-risk transplant period.
This trial tests whether taking a fiber supplement by mouth during a donor stem cell transplant helps patients tolerate treatment and potentially recover better. It’s specifically for adults who are planning a donor (allogeneic) transplant for blood cancers.
This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.
This trial tests if a drug combo (cyclophosphamide, sirolimus, and ruxolitinib) works better than another combo (cyclophosphamide, sirolimus, and mycophenolate mofetil) to prevent graft versus host disease in people getting a stem cell transplant for certain blood cancers.
Hear when a new Allogeneic Stem Cell Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.